echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Hengrui Pharmaceutical iodxaol injection application approved in Germany

    Hengrui Pharmaceutical iodxaol injection application approved in Germany

    • Last Update: 2020-06-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    recently,
    theof its sub-
    company(http://, Cadiasun Pharma GmbH, received a letter of approval from the German FederalPharmaceutical(http://and theResearch Institute ofMedical Devices
    (http:// to approve the company's application for listing of iodxaol injections in Germany, the http://on iodxaol injection
    Iodsaol injection is an X-ray contrast agent, suitable for adult cardiovascular contrast, cerebrovascular angiography (conventional), peripheral arterial imaging (routine), excretion urinary tract angiography and computer tomography (CT), can make abnormal structure or lesions development, to distinguish betweenhealthy(http://tissues and pathological tissueshis indications include lumbar, thoracic and cervical spinal imaging and gastrointestinal tract (oral and rectum) examinations, as well as cardiovascular imaging, excretion urinary tract imaging, CT enhancement and upper digestive tract examination in childreniodxaol injections developed by NorwegianPharmaceutical(http://Pharmaceuticals(http://named Iodixanol Injection, a product called VISIPAQUEThe drug was first introduced in 1994 in Sweden, the United Kingdom, Switzerland and other European countries, and is currently listed in China, the United States, Japan, France and other countries and regions
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.